129
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Clinic, Anthropometric And Metabolic Changes In Adults With Class III Obesity Classified As Metabolically Healthy And Metabolically Unhealthy

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 2419-2431 | Published online: 27 Nov 2019

References

  • Ng M , Fleming T , Robinson M , et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the global burden of disease study 2013. Lancet . 2014;384::766–781. doi:10.1016/S0140-6736(14)60460-8
  • NCD. Risk factor collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet . 2016;387(10026):1377–1396. doi:10.1016/S0140-6736(16)30054-X 27115820
  • National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation . 2002;106:3143–3421.12485966
  • Dervaux N , Wubuli M , Megnien JL , Chironi G , Simon A . Comparative associations of adiposity measures with cardiometabolic risk burden in asymptomatic subjects. Atherosclerosis . 2008;201(2):413–417. doi:10.1016/j.atherosclerosis.2007.11.032 18191136
  • Choi KM . Sarcopenia and sarcopenic obesity. Korean J Intern Med . 2016;31(6):1054–1060. doi:10.3904/kjim.2016.193 27809450
  • Tovo C , Fernandes SA , Buss C , de Mattos AA . Sarcopenia and non-alcoholic fatty liver disease: is there a relationship? A systematic review. World J Hepatol . 2017;28(9):326–332. doi:10.4254/wjh.v9.i6.326
  • Chen YY , Fang WH , Wang CC , et al. Body fat has stronger associations with bone mass density than body mass index in metabolically healthy obesity. PLoS One . 2018;13(11):e0206812. doi:10.1371/journal.pone.0206812 30408060
  • Bano G , Trevisan C , Carraro S , et al. Inflammation and sarcopenia: a systematic review and meta-analysis. Maturitas . 2017;96:10–15. doi:10.1016/j.maturitas.2016 28041587
  • Fazel Y , Koenig AB , Sayiner M , Goodman ZD , Younossi ZM . Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism . 2016;65(8):1017–1025. doi:10.1016/j.metabol.2016.01.012 26997539
  • Targher G , Lonardo A , Rossini M . Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link? J Endocrinol Invest . 2015;38(8):817–882. doi:10.1007/s40618-015-0315-6 26003827
  • Wolf E , Utech M , Stehle P , Büsing M , Stoffel-Wagner B , Ellinger S . Preoperative micronutrient status in morbidly obese patients before undergoing bariatric surgery: results of a cross-sectional study. Surg Obes Relat Dis . 2015;11(5):1157–1163. doi:10.1016/j.soard.2015.03.018 25980331
  • Via MA , Mechanick JI . Nutritional and micronutrient care of bariatric surgery patients: current evidence update. Curr Obes Rep . 2017;6(3):286–296. doi:10.1007/s13679-017-0271-x 28718091
  • Faé C , Liberali R , Coutinho VF . Deficiência de nutrientes a longo prazo no pós-operatório de cirurgia bariátrica – revisão sistemática. SaBios . 2015;10(2):46–53.
  • Manoy P , Anomasiri W , Yuktanandana P , et al. Elevated serum leptin levels are associated with low vitamin D, sarcopenic obesity, poor muscle strength, and physical performance in knee osteoarthritis. Biomarkers . 2017;19:1–8. doi:10.1080/1354750X.2017.1315615
  • Chen XX , Yang T . Roles of leptin in bone metabolism and bone diseases. J Bone Miner Metab . 2015;33(5):474–485. doi:10.1007/s00774-014-0569-7 25777984
  • Hashimoto Y , Hamaguchi M , Fukuda T , Ohbora A , Kojima T , Fukui M . Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals. Endocrine . 2017;57(1):89–97. doi:10.1007/s12020-017-1313-6 28508194
  • Yang CW , Li CI , Li TC , et al. Association of sarcopenic obesity with higher serum high-sensitivity C-reactive protein levels in chinese older males – a community-based study (Taichung Community Health Study-Elderly, TCHS-E). PLoS One . 2015;10(7):e0132908. doi:10.1371/journal.pone.0132908 26177029
  • JafariNasabian P , Inglis JE , Kelly OJ , Ilich JZ , Jafari-Narsabian. Osteosarcopenic obesity in women: impact, prevalence, and management challenges. Int J Womens Health . 2017;9:33–42. doi:10.2147/IJWH.S106107 28144165
  • Szeljf C , Parra-Rodriguéz L , Rosas-Carrasco O . Osteosarcopenic obesity: prevalence and relation with frailty and physical performance in middle-aged and older women. J Am Med Dir Assoc . 2017;18(8):733e1–733e5. doi:10.1016/j.jamda.2017.02.023
  • Cabral JAV , Souza GP , Nascimento JA , Simoneti LF , Marchese C , Sales-Peres SH . Impact of vitamin D and calcium deficiency in the bones of patients undergoing bariatric surgery: a systematic review. Arq Bras Cir Dig . 2016;29(1 Suppl. 1)):120–123. doi:10.1590/0102-6720201600S10029
  • Bekaert M , Verhelst X , Geerts A , Lapauw B , Calders P . Association of recently described adipokines with liver histology in biopsy proven non-alcoholic fatty liver disease: a systematic review. Obes Rev . 2016;17(1):68–80. doi:10.1111/obr.12333
  • Liu C , Wang C , Guan S , et al. The prevalence of metabolically healthy and unhealthy obesity according to different criteria. Obes Facts . 2019;12(1):78–90. doi:10.1159/000495852 30814477
  • Primeau V , Coderre L , Karelis AD , et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes . 2011;35:971e81. doi:10.1038/ijo.2010.216
  • Estrella ML , Pirzada A , Durazo-Arvizu RA , et al. Correlates of and Body Composition Measures Associated with metabolically healthy obesity phenotype in hispanic/latino women and men: the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). J Obes . 2019;2019:1–10. doi:10.1155/2019/1251456
  • Stefan N , Häring HU , Hu FB , Schulze MB . Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol . 2013;1(2):152–162. doi:10.1016/S2213-8587(13)70062-7 24622321
  • Lassale C , Tzoulaki I , Moons KGM , et al. Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis. Eur Heart J . 2018;39(5):397–406. doi:10.1093/eurheartj/ehx44 29020414
  • Bell JA , Kivimaki M , Hamer M . Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies. Obes Rev . 2014;15(6):504–515. doi:10.1111/obr.12157 24661566
  • Zheng R , Zhou D , Zhu Y . The long-term prognosis of cardiovascular disease and all-cause mortality for metabolically healthy obesity: a systematic review and meta-analysis. J Epidemiol Community Health . 2016;70(10):1024–1031. doi:10.1136/jech-2015-206948 27126492
  • Hinnouho GM , Czernichow S , Dugravot A , Batty GD , Kivimaki M , Singh-Manoux A . Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter? Diabetes Care . 2013;36:2294–2300. doi:10.2337/dc12-1654 23637352
  • Phillips CM . Metabolically healthy obesity: personalised and public health implications. Trends Endocrinol Metab . 2016;27(4):189–191. doi:10.1016/j.tem.2016.02.001 26915289
  • Ortega FB , Lavie CJ , Blair SN . Obesity and cardiovascular disease. Circ Res . 2016;118:1752e70. doi:10.1161/CIRCRESAHA.115.306883 27230640
  • Pujia A , Gazzaruso C , Ferro Y , et al. Individuals with metabolically healthy overweight/obesity have higher fat utilization than metabolically unhealthy individuals. Nutrients . 2016;8(1):2. doi:10.3390/nu8010002
  • Chang Y , Jung HS , Zhang Y , et al. Metabolically healthy obesity and the development of nonalcoholic fatty liver disease. Am J Gastroenterol . 2016;111(8). doi:10.1038/ajg.2016.178
  • Blüher S . Schwarz:metabolicallyhealthy obesity from childhood to adulthood – does weight status alone matter? Metabolism . 2014;63(9):1084–1092. doi:10.1016/j.metabol.2014.06.009 25038727
  • World Health Organization (WHO). Obesity: Preventing and Managing the Global Epidemic . Geneva: WHO; 2004.
  • National Kidney Foundation. KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. 2002 Available from: https://www.kidney.org/sites/default/files/docs/ckd_evaluation_classification_stratification.pdf Accessed 11 20, 2017.
  • Grundy SM , Cleeman JI , Merz CN , et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation . 2004;110(2):227–239. doi:10.1161/01.CIR.0000133317.49796.0E 15249516
  • Lohman T , Caballero B , Davis S . Pathways: A school-based program for the primary prevention of obesity in American Indian children. J Nutr Sept . 1998;9(9):535–543.
  • Amato MC , Giordano C , Galia M , et al. Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Car . 2010;33(4):920–922. doi:10.2337/dc09-1825
  • Craig CL , Marshall AL , Sjostrom M , et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc . 2003. doi:10.1249/01.MSS.0000078924.61453.FB
  • Pratt DS , Kaplan MM . Avaliação da função hepática [Liver function assessment] In: Braunwald E , Fauci AS , Kasper DL , Hauser SL , Longo DL , Jameson LR , editors. Harrison Medicina Interna [harrison Internal Medicine] . 15th ed. Rio de Janeiro: Mc Graw Hill; 2002:1813–1816.
  • Sociedade Brasileira de Cardiologia (SBC). VII Diretriz Brasileira de Hipertensão Arterial. 2016 Available from:http://publicacoes.cardiol.br/2014/diretrizes/2016/05_HIPERTENSAO_ARTERIAL.pdf Accessed 2 2, 2016.
  • Friedewald WT , Levy RI , Fredrickson DS . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem . 1972;18(6):499–502.4337382
  • Matthews DR , Hosker JP , Rudenski AS , Naylor BA , Treacher DF , Turner RC . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia . 1985;28(7):412–419. doi:10.1007/bf00280883 3899825
  • Durward CM , Hartman TJ , Nickols-Richardson SM . All-cause mortality risk of metabolically healthy obese individuals in NHANES III. J Obes . 2012;2012:460321. doi:10.1155/2012/460321 23304462
  • Pearson TA , Mensah GA , Alexander RW , et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation . 2003;107:499–511. doi:10.1161/01.cir.0000052939.59093.45 12551878
  • Kao PC . Parathyroid hormone assay. Mayo Clin Proc . 1982.
  • Bramer JA , Abudu AA , Tillman RM , Carrter SR , Sumathi VP , Grimer RJ . Pre and post chemotherapy alkaline phosphatase levels as prognostic indicators in adults with localized osteosarcoma. Eur J Cancer . 2005;41(18):2846–2852. doi:10.1016/j.ejca.2005.07.024 16274987
  • Holick MF , Chen TC . Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr . 2008;87(4):1080S–6S. doi:10.1093/ajcn/87.4.1080S 18400738
  • Hanwell HEC , Vieth R , Cole DE , et al. Sun exposure questionnaire predicts circulating 25-hydroxyvitamin D concentrations in Caucasian hospital workers in southern Italy. J Steroid Biochem Mol Biol . 2010;121(1–2):334–337. doi:10.1016/j.jsbmb.2010.03.023 20298782
  • Daly JA , Ertingshausen G . Direct method for determining inorganic phosphate in serum with the “centrifiChem”. Clin Chem . 1972;18(3):263–265.5020822
  • World Health Organization (WHO). The World Health Report, Fighting Disease, Fostering Development. 1996 Available from: www.who.int/whr/1996/en/ Accessed 6 6, 2016.
  • IBM Cor:Released. IBM SPSS Statistics for Windows, Version 21.0 . Armonk, NY: IBM Corp; 2012.
  • Goday A , Calvo E , Vázquez LA , et al. Prevalence and clinical characteristics of metabolically healthy obese individuals and other obese/non-obese metabolic phenotypes in a working population: results from the Icaria study. BMC Public Health . 2016;16:248. doi:10.1186/s12889-016-2921-4 27036105
  • Latifi SM , Karandish M , Shahbazian H , Taha JM , Cheraghian B , Moradi M . Prevalence of Metabolically Health Y Obesity (MHO) and its relation with incidence of metabolic syndrome, hypertension and type 2 diabetes amongst individuals aged over 20 years in Ahvaz: a 5 year cohort study (2009–2014). Diabetes Metab Syndr . 2017;11(Suppl.2):S1037–S1040. doi:10.1016/j.dsx.2017.07.036 28781161
  • Diniz MFH , Beleigoli AMR , Ribeiro ALP , et al. Factors associated with metabolically healthy status in obesity, overweight, and normal weight at baseline of ELSA-Brasil. Medicine . 2016;95(27):e4010. doi:10.1097/MD.0000000000004010 27399079
  • Hwang YC , Hayashi T , Fujimoto WY , et al. Visceral abdominal fat accumulation predicts the conversion of metabolically healthy obese subjects to an unhealthy phenotype. Int J Obes (Lond) . 2015;39(9):1365–1370. doi:10.1038/ijo.2015.75 25920773
  • Phillips CM . Metabolically healthy obesity: definitions, determinants and clinical implications. Rev Endocr Metab Disord . 2013;14(3):219–227. doi:10.1007/s11154-013-9252-x 23928851
  • Van Vliet-Ostaptchouk JV , Noutio ML , Slagter SN , et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr Disord . 2014;14:9. doi:10.1186/1472-6823-14-9 24484869
  • Stefan N , Haring HU , Hu FB , Schulze MB . Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol . 2013;1(2):152–162. doi:10.1016/S2213-8587(13)70062-7 24622321
  • Phillips CM . Metabolically healthy obesity across the life course: epidemiology, determinants, and implications. Ann N Y Acad Sci . 2017;1391(1):85–100. doi:10.1111/nyas.13230 27723940
  • Arnlov J , Sundstrom J , Ingelsson E , Lind L . Impact of BMI and the metabolic syndrome on the risk of diabetes in middle-aged men. Diabetes Care . 2011;34(1):61–65. doi:10.2337/dc10-0955 20852030
  • Hamer M , Bell JA , Sabia S , Batty GD , Kivimaki M . Stability of metabolically healthy obesity over 8 years: the english longitudinal study of ageing. Eur J Endocrinol . 2015;173(5):703–708. doi:10.1530/eje-15-0449 26286585
  • Schröder H , Ramos R , Baena-Díez JM , et al. Determinants of the transition from a cardiometabolic normal to abnormal overweight/obese phenotype in a Spanish population. Eur J Nutr . 2014;53(6):1345–1353. doi:10.1007/s00394-013-0635-2 24322835
  • Bell LK , Edwards S , Grieger JA . The relationship between dietary patterns and metabolic health in a representative sample of adult Australians. Nutrients . 2015;7(8):6491–6505. doi:10.3390/nu7085295 26251918
  • de Rooij BH , van der Berg JD , van der Kallen CJ , et al. Physical activity and sedentary behavior in metabolically healthy versus unhealthy obese and nonobese individuals – the maastricht study. PLoS One . 2016;11(5):e0154358. doi:10.1371/journal.pone.0154358 27138596
  • Donini LM , Merola G , Poggiogalle E , et al. Disability, physical inactivity, and impaired health-related quality of life are not different in metabolically healthy Vs. unhealthy obese subjects. Nutrients . 2016;8(12):759. doi:10.3390/nu8120759
  • Abenavoli L , Peta V . Role of adipokines and cytokines in non-alcoholic fatty liver disease. Rev Recent Clin Trials . 2014;9(3):134–140.25514909
  • Kim HT , Kim HJ , Ahn HY , Hong YH . An analysis of age-related loss of skeletal muscle mass and its significance on osteoarthritis in a Korean population. Korean J Intern Med . 2016;31(3):585–593. doi:10.3904/kjim.2015.156 26976151
  • Lee TH , Jeon WS , Han KJ , et al. Comparison of serum adipocytokine levels according to metabolic health and obesity status. Endocrinol Metab (Seoul) . 2015;30(2):185–194. doi:10.3803/EnM.2015.30.2.185 25325281
  • Shaharyar S , Roberson LL , Jamal O , et al. Obesity and metabolic phenotypes (metabolically healthy and unhealthy variants) are significantly associated with prevalence of elevated c-reactive protein and hepatic steatosis in a large healthy brazilian population. J Obes . 2015;2015. doi:10.1155/2015/178526
  • Cordeiro A , Pereira A , Saboya CJ , Ramalho A . Relationship between nonalcoholic fatty liver disease and vitamin D nutritional status in extreme obesity. Can J Gastroenterol Hepatol . 2017;2017. doi:10.1155/2017/9456897
  • Cordeiro A , Pereira SE , Saboya SE , Ramalho A . Nonalcoholic fatty liver disease relationship with metabolic syndrome in class III obesity individuals. Biomed Res Int . 2015;2015:839253. doi:10.1155/2015/839253 26120587
  • Huh JH , Kim KJ , Kim SU , et al. Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status. Metabolism . 2017;66:23–31. doi:10.1016/j.metabol.2016.10.003 27923446
  • Walsh JS , Bowles S , Evans AL . Vitamin D in obesity. Curr Opin Endocrinol Diabetes Obes . 2017;24(6):389–394. doi:10.1097/MED.0000000000000371 28915134
  • Avenell A , Mak JC , O’Connell D . Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev . 2014;4:1–170. doi:10.1002/14651858.CD000227.pub4
  • Kim TN , Park MS , Lim KI , et al. Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean Sarcopenic Obesity Study. Clin Endocrinol (Oxf) . 2013;78(40):525–532. doi:10.1111/j.1365-2265.2012 22563924
  • Severson TJ , Besur S , Bonkovsky HL . Genetic factors that affect nonalcoholic fatty liver disease: a systematic clinical review. World J Gastroenterol . 2016;22(29):6742–6756. doi:10.3748/wjg.v22.i29.6742 27547017
  • Murray TÉ , Williams D , Lee MJ . Osteoporosis, obesity, and sarcopenia on abdominal CT: a review of epidemiology, diagnostic criteria, and management strategies for the reporting radiologist. Abdom Radiol (NY) . 2017;42(9):2376–2386. doi:10.1007/s00261-017-1124-5 28386693
  • Christakos S , Dhawan P , Porta A , Mady LJ , Seth T . Vitamin D and intestinal calcium absorption. Mol Cell Endocrinol . 2011;347(1–20):25–29. doi:10.1016/j.mce.2011.05.038 21664413
  • Walsh JS , Evans AL , Bowles S , et al. Free 25-hydroxyvitamin D is low in obesity, but there are no adverse associations with bone health. Am J Clin Nutr . 2016;103(6):1465–1471. doi:10.3945/ajcn.115.120139 27169839
  • Samuel L , Borrell LN . The effect of body mass index on optimal vitamin D status in U.S. adults: the National Health and Nutrition Examination Survey 2001–2006. Ann Epidemiol . 2013;23(7):409–414. doi:10.1016/j.annepidem.2013.05.011 23790345
  • Vimaleswaran KS , Berry DJ , Lu C , et al. Causal relationship between obesity and vitamin D status: bi-directional mendelian randomization analysis of multiple cohorts. PLoS Med . 2013;10(2):1–13. doi:10.1371/journal.pmed.1001383
  • Seo JA , Cho H , Eun CR , et al Association between visceral obesity and sarcopenia and vitamin D deficiency in older Koreans: the Ansan Geriatric Study. J Am Geriatr Soc . 2012;60(4):700–706. doi:10.1111/j.1532-5415.2012.03887.x 22316299
  • Wimalawansa SJ . Vitamin D deficiency is a surrogate marker for visceral fat content, metabolic syndrome, type 2 diabetes, and future metabolic complications. J Diabetes Metab Disord Control . 2016;3(1):00059. doi:10.15406/jdmdc.2016.03.00059
  • Kull M , Kallikorm R , Lember M . Body mass index determines sunbathing habits: implications on vitamin D levels. Intern Med J . 2009;39(4):256–258. doi:10.1111/j.1445-5994.2009.01900.x 19402866
  • Shea MK , Houston DK , Tooze JA , et al. Correlates and prevalence of insufficient 25-hydroxyvitamin D status in black and white older adults: the health, aging and body composition study. J Am Geriatr Soc . 2011;59(7):1165–1174. doi:10.1111/j.1532-5415.2011.03476.x 21668915
  • Winters SJ , Chennubhatla R , Wang C , Miller JJ . Influence of obesity on vitamin D-binding protein and 25-hydroxy vitamin D levels in African American and white women. Metabolism . 2009;58(4):438–442. doi:10.1016/j.metabol.2008.10.017 19303961
  • Fischer V , Haffnet-Luntzer M , Prystaz K , et al. Calcium and vitamin-D deficiency marginally impairs fracture healing but aggravates posttraumatic bone loss in osteoporotic mice. Sci Re . 2017;7:7223. doi:10.1038/s41598-017-07511-2
  • Ormsbee MJ , Prado CM , Ilich JZ , et al. Osteosarcopenic obesity: the role of bone, muscle, and fat on health. J Cachexia Sarcopenia Muscle . 2014;5(3):183–192. doi:10.1007/s13539-014-0146-x 24740742
  • Kelly OJ , Gilman JC , Kim Y , Ilich JZ . Micronutrient intake in the etiology, prevention and treatment of osteosarcopenic obesity. Curr Aging Sci . 2016;9(4):260–268.27156952
  • Lo Menzo E , Cappellani A , Zanghì A , Di Vita M , Berretta M , Szomstein S . Nutritional implications of obesity: before and after bariatric surgery. Bariatr Surg Pract Patient Care . 2014;9(1):9–17. doi:10.1089/bari.2014.9969 24761370
  • Demirağ MD , Özkan S , Haznedaroğlu Ş , et al. Associations between obesity and the radiographic phenotype in knee osteoarthritis. Turk J Med Sci . 2017;47(2):424–429. doi:10.3906/sag-1512-26 28425275
  • Poonpet T , Honsawek S . Adipokines: biomarkers for osteoarthritis? World J Ortho . 2014;5(3):319–327. doi:10.5312/wjo.v5.i3.319
  • Dutra MT , Avelar BP , Souza VC , et al. Relationship between sarcopenic obesity-related phenotypes and inflammatory markers in postmenopausal women. Clin Physiol Funct Imaging . 2017;37(2):205–210. doi:10.1111/cpf.12287 26373437
  • Gonçalves CG , Glade MJ , Meguid MM . Metabolically healthy obese individuals: key protective factors. Nutrition . 2016;32(1):14–20. doi:10.1016/j.nut.2015.07.010 26440861
  • Snijder MB , Van Dam RM , Visser M , et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab . 2005;90(1):4119–4123. doi:10.1210/jc.2005-0216 15855256
  • Vilaça T . Obesidade, Doenças Osteometabólicas, Gota e Osteoartrose In: Mancini CM , Geloneze B , Salles JE , Lima JG , Carra M , editors. Tratado De Obesidade . 2nd ed. Rio de Janeiro: Guanabara Koogan; 2015:319–326.
  • Cusano NE , Rubin MR , Irani D , Sliney J Jr , Bilezikian JP . Use of parathyroid hormone in hypoparathyroidism. J Endocrino Invest . 2013;36(11):1121–1127. doi:10.1007/BF03346763